Affiliation:
1. Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21205
2. Veterinary Molecular Biology, Montana State University, Bozeman, Montana 59717-3610
Abstract
ABSTRACT
Antibodies to K99 fimbriae afford protection to F5
+
bovine enterotoxigenic
Escherichia coli
(ETEC). Previous studies show that murine dams immunized with
Salmonella
vaccine vectors stably expressing K99 fimbriae confer protection to ETEC-challenged neonatal pups. To begin to address adaptation of the K99 scaffold to display heterologous B- and T-cell epitopes, studies were conducted to determine how much of the assembled K99 fimbria is required to maintain protective immunity. Sequential deletions in the K99 gene clusters were made, resulting in diminished localization of the K99 fimbrial subunit in the outer membrane. As placement of the K99 fimbrial subunit became progressively contained within the vaccine vector, diminished immunoglobulin A (IgA) and IgG1 antibody titers, as well as diminished Th2-type cytokine responses, were observed in orally immunized mice. Deletion of
fanGH
, which greatly reduced the export of the fimbrial subunit to the outer membrane, showed only partial reduction in protective immunity. By contrast, deletion of
fanDEFGH
, which also reduced the export of the fimbrial subunit to the outer membrane but retained more subunit in the cytoplasm, resulted in protective immunity being dramatically reduced. Thus, these studies showed that retention of K99 fimbrial subunit as native fimbriae or with the deletion of
fanGH
is sufficient to confer protection.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference56 articles.
1. Oral Immunization with a
Salmonella typhimurium
Vaccine Vector Expressing Recombinant Enterotoxigenic
Escherichia coli
K99 Fimbriae Elicits Elevated Antibody Titers for Protective Immunity
2. Bayer, M., K. Bischof, R. Noiges, and G. Koraimann. 2000. Subcellular localization and processing of the lytic transglycosylase of the conjugative plasmid R1. FEBS Lett.466:389-393.
3. Black, R. E. 1992. Epidemiology of diarrhoeal disease: implications for control by vaccines. Vaccine11:100-106.
4. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology (N.Y.)10:888-892.
5. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献